Conduit Pharmaceuticals Inc (CDT) Stock Price, Quote & News

Company Profile

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has stra...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 491 9132

Website: www.conduitpharma.com

Address:

4581 Tamiami Trail North, Suite 200, Naples, United States

ProfessorDman1 May. 12 at 7:23 PM

$CDT I would load everything here sub $2 buy ins : $PBM $TDIC $BZFD $ERNA

1 · Reply

ka1954 May. 11 at 10:37 PM

$CDT everyday for last few years down down down

0 · Reply

Nevilhch May. 11 at 7:19 PM

$CDT jajajajaa retards

0 · Reply

Sam201 May. 11 at 7:05 PM

$CDT 2k more to 20k!

0 · Reply

ka1954 May. 11 at 4:33 PM

$CDT daily volume is so low. idiots retails selling this now.

0 · Reply

Nevilhch May. 8 at 7:14 PM

$CDT I bet there will be another 100 million diluted shares... and some people are still promoting this piece of crap🤦🤦🤦

0 · Reply

Bears2354 May. 8 at 4:18 PM

$CDT

0 · Reply

ka1954 May. 8 at 3:41 PM

$CDT this company is total shit

0 · Reply

Nevilhch May. 8 at 3:38 PM

$CDT Delist this shitty company now! This SEC is a joke!

0 · Reply

Sam201 May. 7 at 9:39 PM

$CDT you lost n I feel sorry. Everyone of us have lost here or somewhere else. Timing matters and it’s time to load back!

1 · Reply

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

2026-05-07T04:50:30.000Z - 6 days ago

CDT Equity announces AZD5904 progresses into patent cooperation treaty phase

AZN

May 6, 2026, 8:30 AM EDT - 7 days ago

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

2026-04-27T16:25:54.000Z - 15 days ago

CDT Equity management to meet with Maxim

2026-04-22T10:10:41.000Z - 21 days ago

CDT Equity files to sell 5.35M shares of common stock for holders

2026-04-20T17:25:11.000Z - 22 days ago

CDT Equity management to meet with Maxim

2026-04-16T12:47:10.000Z - 27 days ago

CDT Equity expands multi-pathway value creation strategy across pharma, IP

AZN

Apr 16, 2026, 8:30 AM EDT - 27 days ago

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

Apr 7, 2026, 8:30 AM EDT - 5 weeks ago

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

2026-03-27T13:45:58.000Z - 6 weeks ago

CDT Equity Inc trading resumes

2026-03-27T13:35:40.000Z - 6 weeks ago

CDT Equity Inc trading halted, volatility trading pause

2026-03-26T23:50:31.000Z - 6 weeks ago

CDT Equity Inc trading halted, news pending

2026-03-26T13:17:06.000Z - 6 weeks ago

CDT Equity expands Tapinarof intellectual property portfolio with patent filings

Mar 26, 2026, 8:30 AM EDT - 6 weeks ago

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

2026-03-25T12:27:39.000Z - 7 weeks ago

CDT Equity announces 1-for-25 reverse stock split

Mar 25, 2026, 8:00 AM EDT - 7 weeks ago

CDT Equity Inc. Announces Reverse Stock Split

Mar 23, 2026, 8:30 AM EDT - 7 weeks ago

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

2026-03-18T12:46:14.000Z - 2 months ago

CDT Equity announces stockholders approved all proposals at Special Meeting

Mar 18, 2026, 8:30 AM EDT - 2 months ago

CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth

2026-03-12T12:36:57.000Z - 2 months ago

CDT Equity notes Sarborg expansion into rare disease signature intelligence

Mar 12, 2026, 8:30 AM EDT - 2 months ago

CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

2026-03-05T13:47:10.000Z - 2 months ago

CDT Equity notes Sarborg filing of U.S. provisional patent application

Mar 5, 2026, 8:30 AM EST - 2 months ago

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

2026-03-04T13:38:28.000Z - 2 months ago

CDT Equity says advancing multiple initiatives to enhance shareholder value

AZN

Mar 4, 2026, 8:30 AM EST - 2 months ago

CDT Positions for Transformational Growth

2026-02-24T13:39:45.000Z - 2 months ago

CDT Equity notes Sarborg expansion into bacteria, agrochemicals

Feb 24, 2026, 8:30 AM EST - 2 months ago

CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals

2026-02-20T13:36:27.000Z - 2 months ago

CDT Equity entered into a transaction to acquire a 20% equity stake in Sarborg

Feb 20, 2026, 8:30 AM EST - 2 months ago

CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy

2026-01-30T11:11:57.000Z - 3 months ago

CDT Equity files to sell 22.85M shares of common stock for holders

2026-01-02T13:40:26.000Z - 4 months ago

CDT Equity engages NJS Foresight Bio-Advisory for out-licensing strategy

Jan 2, 2026, 8:30 AM EST - 4 months ago

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

2025-11-28T14:05:17.000Z - 5 months ago

CDT Equity announces results of annual general meeting

2025-10-17T12:35:29.000Z - 7 months ago

CDT Equity acquires 9 bitcoin for $1M

Oct 17, 2025, 8:30 AM EDT - 7 months ago

CDT Equity Increases Bitcoin Holding

Sep 17, 2025, 8:30 AM EDT - 8 months ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

Aug 26, 2025, 8:30 AM EDT - 9 months ago

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Aug 5, 2025, 8:30 AM EDT - 10 months ago

Conduit to Change Name to CDT Equity Inc.

Jul 8, 2025, 8:30 AM EDT - 11 months ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 7, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jun 4, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

May 22, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 21, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 16, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 9, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 8, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Leadership Changes

Apr 11, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 6, 2025, 9:35 AM EST - 1 year ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Feb 20, 2025, 8:00 AM EST - 1 year ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 13, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 11, 2025, 9:00 AM EST - 1 year ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 7, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Jan 28, 2025, 5:30 AM EST - 1 year ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Dec 12, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Nov 21, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 19, 2024, 4:30 PM EST - 1 year ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 4, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 1, 2024, 4:45 PM EDT - 1 year ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 8, 2024, 6:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

May 22, 2024, 7:00 AM EDT - 2 years ago

AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024

AZN

May 21, 2024, 8:00 AM EDT - 2 years ago

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

Mar 19, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Mar 11, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Jan 31, 2024, 8:30 AM EST - 2 years ago

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Oct 11, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

ProfessorDman1 May. 12 at 7:23 PM

$CDT I would load everything here sub $2 buy ins : $PBM $TDIC $BZFD $ERNA

1 · Reply

ka1954 May. 11 at 10:37 PM

$CDT everyday for last few years down down down

0 · Reply

Nevilhch May. 11 at 7:19 PM

$CDT jajajajaa retards

0 · Reply

Sam201 May. 11 at 7:05 PM

$CDT 2k more to 20k!

0 · Reply

ka1954 May. 11 at 4:33 PM

$CDT daily volume is so low. idiots retails selling this now.

0 · Reply

Nevilhch May. 8 at 7:14 PM

$CDT I bet there will be another 100 million diluted shares... and some people are still promoting this piece of crap🤦🤦🤦

0 · Reply

Bears2354 May. 8 at 4:18 PM

$CDT

0 · Reply

ka1954 May. 8 at 3:41 PM

$CDT this company is total shit

0 · Reply

Nevilhch May. 8 at 3:38 PM

$CDT Delist this shitty company now! This SEC is a joke!

0 · Reply

Sam201 May. 7 at 9:39 PM

$CDT you lost n I feel sorry. Everyone of us have lost here or somewhere else. Timing matters and it’s time to load back!

1 · Reply

ALLEGEDLY01 May. 7 at 5:32 PM

$KITT $INHD $TOPS $CDT $JAGX

0 · Reply

Edopas May. 7 at 12:34 PM

$CDT don’t fall for this stock and it’s news. They are always going through a reverse split. Avoid this stock as much as possible if you don’t want to lose your hard earned money. Not sure why it is still listed though

0 · Reply

ProfessorDman1 May. 7 at 12:33 PM

$CDT 100%+ move next Like we saw $PMAX

2 · Reply

ProfessorDman1 May. 7 at 12:31 PM

$CDT - CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market ( News out )

0 · Reply

ProfessorDman1 May. 6 at 9:58 PM

$PMAX 140% from $2 to all the way $4.81 $CDT setting up 2.28 now from 2 next one to go soon 3-5 range possible tomorrow

0 · Reply

ProfessorDman1 May. 6 at 7:18 PM

$CDT high borrow fee 2 right now That’s how $PMAX started from 2 now 100%

0 · Reply

ProfessorDman1 May. 6 at 6:17 PM

$CDT $3+ next 💪 If you missed $PMAX from 2-3.75 near 100% and still going

0 · Reply

ALLEGEDLY01 May. 6 at 4:19 PM

Market Conditions are TOO GOOD for swingers, always trust your first guess and dont over trade. lots of shiny objects these days. Trade 3x a week if you have a full time job/ business other than trading; add small and sell strong. Here are my big 5: $CDT $KITT $JAGX $INHD $TOPS

0 · Reply

Sam201 May. 6 at 2:39 PM

$CDT ?? Fidelity n Robinhood n most others are allowing. Nice try though..

1 · Reply

falcon630 May. 6 at 1:38 PM

$CDT You guys keep tagging this stock but most brokers won't let you buy CDT

1 · Reply

ProfessorDman1 May. 6 at 1:29 PM

$PMAX $2 to $3+ so far 50%+ move $CDT same chart 📊 identical move in play

1 · Reply

DARKP00L May. 6 at 12:51 PM

$CDT 08:40 on May. 06 2026 CDT Equity Begins Seeking Patent Cooperation And Licensing Partners For Male Infertility Treatment AZD5904 #tradeideas

0 · Reply

Market Cap	5.41M
Revenue (ttm)	0.00
Net Income (ttm)	-17.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	109,702
Avg Vol	422,744
Day's Range	N/A - N/A
Shares Out	2.93M
Stochastic %K	5%
Beta	1.93
Analysts	Strong Buy
Price Target	N/A